These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 18310863)

  • 1. Contrast media nephropathy: in depth review.
    Hussain N; Al Otaibi T; Nampoory MR
    Saudi J Kidney Dis Transpl; 2008 Mar; 19(2):174-82. PubMed ID: 18310863
    [No Abstract]   [Full Text] [Related]  

  • 2. Preventing contrast nephropathy: what is the best strategy? A review of the literature.
    Cox CD; Tsikouris JP
    J Clin Pharmacol; 2004 Apr; 44(4):327-37. PubMed ID: 15051739
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Complications after administration of contrast media in high-risk patients. Is a prophylactic dialysis meaningful?].
    Liebl R; Krämer BK
    Dtsch Med Wochenschr; 1996 Nov; 121(47):1475-9. PubMed ID: 8983899
    [No Abstract]   [Full Text] [Related]  

  • 4. Prevention of contrast media nephrotoxicity--the story so far.
    Morcos SK
    Clin Radiol; 2004 May; 59(5):381-9. PubMed ID: 15081843
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [New usage for an old drug: acetylcysteine for contrast-induced nephropathy].
    Asher I; Hammerman A; Sthoeger Z
    Harefuah; 2005 Sep; 144(9):642-6; 675. PubMed ID: 16218537
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Risk factors and therapy strategies for contrast-induced nephropathy.
    Toprak O; Cirit M
    Ren Fail; 2006; 28(5):365-81. PubMed ID: 16825085
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Contrast-induced nephropathy.
    Narang R; Sakhare M; Bahl VK
    Indian Heart J; 2004; 56(1):13-20. PubMed ID: 15129784
    [No Abstract]   [Full Text] [Related]  

  • 8. Acute renal failure.
    Kellum J; Leblanc M; Venkataraman R
    Clin Evid; 2003 Dec; (10):953-76. PubMed ID: 15555131
    [No Abstract]   [Full Text] [Related]  

  • 9. New pharmacological protocols to prevent or reduce contrast media nephropathy.
    Briguori C; Airoldi F; Morici N; Colombo A
    Minerva Cardioangiol; 2005 Feb; 53(1):49-58. PubMed ID: 15788979
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [The use of acetylcysteine for preventing contrast-induced nephropathy].
    Schaad N; Barghouth G
    Rev Med Suisse; 2005 Jun; 1(25):1693-6. PubMed ID: 16117036
    [No Abstract]   [Full Text] [Related]  

  • 11. [Which patients are in risk of contrast media-induced renal damage?].
    Hietala SO; Ryding M
    Lakartidningen; 1992 Mar; 89(11):849-52. PubMed ID: 1545637
    [No Abstract]   [Full Text] [Related]  

  • 12. Review of contrast-induced nephropathy and current use of N-acetylcysteine (NAC).
    Anwar M; Ledger S
    CANNT J; 2005; 15(1):33-8,quiz 38-9. PubMed ID: 15909775
    [No Abstract]   [Full Text] [Related]  

  • 13. Renal failure (acute).
    Kellum J; Leblanc M; Venkataraman R
    Clin Evid; 2006 Jun; (15):1191-212. PubMed ID: 16973048
    [No Abstract]   [Full Text] [Related]  

  • 14. [Contrast medica nephropathy. Better understanding of risk markers and follow up needed].
    Sterner G; Hellström M; Lagerqvist B; Aspelin P; Nyman U
    Lakartidningen; 2009 Jun 24-Jul 7; 106(26-27):1737-42. PubMed ID: 19731735
    [No Abstract]   [Full Text] [Related]  

  • 15. [Contrast-induced nephropathy].
    Westenfeld R; Rump LC
    Dtsch Med Wochenschr; 2013 Apr; 138(14):715-8. PubMed ID: 23533037
    [No Abstract]   [Full Text] [Related]  

  • 16. [N-acetylcysteine protects against radiocontrast-induced nephropathy -- pro].
    Weinbrenner C
    Dtsch Med Wochenschr; 2005 Sep; 130(39):2226. PubMed ID: 16189761
    [No Abstract]   [Full Text] [Related]  

  • 17. Acute renal failure.
    Kellum J; Leblanc M; Venkataraman R
    Clin Evid; 2005 Jun; (13):1070-92. PubMed ID: 16135288
    [No Abstract]   [Full Text] [Related]  

  • 18. Editorial: contrast medium-induced nephropathy.
    Persson PB
    Nephrol Dial Transplant; 2005 Feb; 20 Suppl 1():i1. PubMed ID: 15705942
    [No Abstract]   [Full Text] [Related]  

  • 19. N-acetylcysteine use to prevent contrast medium-induced nephropathy: premature phase III trials.
    Stenstrom DA; Muldoon LL; Armijo-Medina H; Watnick S; Doolittle ND; Kaufman JA; Peterson DR; Bubalo J; Neuwelt EA
    J Vasc Interv Radiol; 2008 Mar; 19(3):309-18. PubMed ID: 18295688
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Atherosclerosis and nephropathy--calcium antagonists in preventive therapy].
    Internist (Berl); 1994 Jan; 35(1 Suppl |atherosk|):1-8. PubMed ID: 9218053
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.